Welcome to the Genome Editing Therapeutics Blog
Discover the latest content related to our upcoming 7th Genome Editing Therapeutics Summit.
The Next Frontier in Genetic Medicine
Can Epigenome Editing Deliver Safer Genetic Therapies? Epicrispr's Latest Data Offers Encouraging Signs...
July 2026
Can Delivery Catch Up With Editing?
As Developers Push Beyond Liver-Targeted Applications, Extrahepatic Delivery has Become One of the Most Important Challenges in Genetic Medicine...
July 2026
Genome Editing at a Crossroads
Innovation is Accelerating. The Question is How the Industry Turns Breakthroughs into Approved Therapies...
July 2026
The FDA's New Rare Disease Pathway
How the Plausible Mechanism Pathway could Accelerate the Next Generation of CRISPR, Base Editing, Prime Editing and Gene-Writing Therapies...
July 2026
The Safety Imperative
How the Industry is Addressing its Most Important Challenge on the Road to Widespread Patient Adoption....
July 2026
From Clinical Breakthrough to Clinical Reality: What’s Next for Genome Editing Therapies?
How Eli Lilly’s VERVE-102 Progress Signals Momentum – But Also the Urgent Need to Advance Clinical Translation Across the Field...
June 2026
From Gene Editing to Gene Writing: The Evolution of Genome Engineering Has Begun
As the Field Moves Beyond Simple Edits, Gene Writing is Unlocking the Ability to Replace, Insert, and Rewrite DNA at Unprecedented Scale...
Coming Soon...
In Vivo vs. Ex Vivo Editing: The Delivery Debate Shaping Genetic Medicine
As Genome Editing Matures, the Strategic Battle Between In Vivo and Ex Vivo Development is Intensifying...
Coming Soon...
Beyond CRISPR-Cas9
CRISPR Started the Revolution, but the Next Generation of Technologies is Pushing Ttherapeutic Genome Engineering Much Further...
Coming Soon...
Explore the Agenda
See exactly which delivery, manufacturing and regulatory sessions are relevant to your genome editing program.
Partner With Us
Put your solutions in front of the genome editing decision-makers actively looking for them.
Join Genome Editing Experts
Connect with the R&D, clinical and regulatory leaders driving genome editing therapeutics forward.